• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYBoard
  • MYInsights
  • Strategy & Consulting
  • Contact Us
Select Page

Brain Nocardiosis Mimicking Intracerebral Invasion on 68Ga-Pentixafor PET/CT in a Patient With Multiple Myeloma

by | Jun 25, 2024 | Publications

Clin Nucl Med. 2024 Jun 21. doi: 10.1097/RLU.0000000000005351. Online ahead of print. ABSTRACT Brain nocardiosis is an uncommon but severe disease associated with high mortality. We present a case of brain nocardiosis with elevated tracer uptake on both...

Receptor T-Cell Chimeric Antigen Approach Used for the Prediction Model Treatment for Relapsed/Refractory Multiple Myeloma

by | Jun 24, 2024 | Publications

J Clin Oncol. 2024 Jun 24:JCO2400544. doi: 10.1200/JCO.24.00544. Online ahead of print. NO ABSTRACT PMID:38913961 | DOI:10.1200/JCO.24.00544

Toll-like receptor signaling in multiple myeloma cells promotes the expression of pro-survival genes B-cell lymphoma 2 and MYC and modulates the expression of B-cell maturation antigen

by | Jun 24, 2024 | Publications

Front Immunol. 2024 Jun 7;15:1393906. doi: 10.3389/fimmu.2024.1393906. eCollection 2024. ABSTRACT Infections are common in plasma cell cancer multiple myeloma (MM) due to disease-related immune deficiencies and cancer treatment. Myeloma cells express Toll-like...

Isolated Abducens Nerve Palsy: A Rare Manifestation of Recurrent Extramedullary Myeloma

by | Jun 24, 2024 | Publications

J Radiol Case Rep. 2024 Jun 1;18(1):14-19. doi: 10.3941/jrcr.v18i1.5240. eCollection 2024. ABSTRACT Multiple myeloma is a plasma cell neoplasm, which may present as a solitary plasmacytoma and, uncommonly, as an extramedullary plasmacytoma. Intracranial plasmacytomas...

High-Output Heart Failure in Multiple Myeloma: Novel Application of Tc-99m MAA to Identify Intramedullary Shunting

by | Jun 24, 2024 | Publications

JACC Case Rep. 2024 Jun 8;29(14):102387. doi: 10.1016/j.jaccas.2024.102387. eCollection 2024 Jul 17. ABSTRACT We introduce the innovative use of technetium-99m-labeled macroaggregated albumin to diagnose high-output heart failure in a patient with multiple myeloma...

Case report: An uncommon presentation of extramedullary plasmacytoma without a concurrent diagnosis of multiple myeloma

by | Jun 24, 2024 | Publications

Front Oncol. 2024 Jun 7;14:1353943. doi: 10.3389/fonc.2024.1353943. eCollection 2024. ABSTRACT INTRODUCTION: Extramedullary plasmacytoma (EMP) is an uncommon solitary tumor originating from neoplastic plasma cells located outside the bone marrow. Despite its rarity,...
« Older Entries
Next Entries »

Recent Content

  • A real-world experience of efficacy and safety of belantamab mafodotin in relapsed refractory multiple myeloma
  • Expert Explains Early Signs, Treatment Advances and Care in Multiple Myeloma
  • Treatment of Multiple Myeloma in Patients Refractory to Daratumumab/Anti-CD38 Monoclonal Antibodies: A Systematic Review
  • Pharmacists Play an Essential Role in Bispecific Therapy for Multiple Myeloma
  • Implications of lymphocyte kinetics after chimeric antigen receptor T cell therapy for multiple myeloma
  • Multiple myeloma as a challenging multidimensional random process: a data-driven web-based application for treatment selection
  • Daratumumab/lenalidomide/dexamethasone in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes
  • Deep Responses in Smoldering Multiple Myeloma Linked to Improved Outcomes
  • Urine-free response criteria predict progression-free survival in multiple myeloma: a post hoc analysis of BMT CTN 0702
  • Deciphering response dynamics and treatment resistance from circulating tumor DNA after CAR T-cells in multiple myeloma
  • Facebook
  • X
  • Instagram
©2016-2024 MYELOMA360
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT